Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 24.38% vs 19.10% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 17.88% vs 25.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 30.13% vs 21.58% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 87.45% vs 4.37% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Dr Agarwal's Eye With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
397.15
913.26
-516.11
-56.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
397.15
913.26
-516.11
-56.51%
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
43.11
0.00
43.11
(Increase) / Decrease In Stocks
-1.16
0.01
-1.17
-11,700.00%
Employee Cost
78.32
143.71
-65.39
-45.50%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
100.94
551.60
-450.66
-81.70%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
57.44
68.10
-10.66
-15.65%
Total Expenditure (Excl Depreciation)
278.65
763.42
-484.77
-63.50%
Operating Profit (PBDIT) excl Other Income
118.50
149.84
-31.34
-20.92%
Other Income
5.09
32.92
-27.83
-84.54%
Operating Profit (PBDIT)
123.59
182.76
-59.17
-32.38%
Interest
13.44
30.48
-17.04
-55.91%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
110.15
152.28
-42.13
-27.67%
Depreciation
39.45
43.02
-3.57
-8.30%
Profit Before Tax
70.70
109.25
-38.55
-35.29%
Tax
16.05
25.80
-9.75
-37.79%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
54.65
83.46
-28.81
-34.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
54.65
83.46
-28.81
-34.52%
Equity Capital
4.70
13.76
-9.06
-65.84%
Face Value
10.00
1.00
0.00
Reserves
204.91
759.55
-554.64
-73.02%
Earnings per share (EPS)
116.28
6.07
110.21
1,815.65%
Diluted Earnings per share
116.28
5.36
110.92
2,069.40%
Operating Profit Margin (Excl OI)
29.84%
16.41%
0.00
13.43%
Gross Profit Margin
27.74%
16.67%
0.00
11.07%
PAT Margin
13.76%
9.14%
0.00
4.62%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 397.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.38% vs 19.10% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 54.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.88% vs 25.57% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 118.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.13% vs 21.58% in Mar 2024
Annual - Interest
Interest 13.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 87.45% vs 4.37% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.84%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
